The Therapeutics Initiative Blog brings you news and information from the world of therapeutics. Bookmark this page to see our frequently refreshed content.
We invite you to watch the keynote address: Is Screening Misunderstood? given at the October 2023 TI Annual Course by Dr. Guylène Thériault MD, CCFP – a family practice physici
In an online article published on September 12, 2023 in UBC CPD’s ‘This Changed My Practice‘ series, Dr. Jill Norris (biography and disclosures) and Dr. Jessica O
As we return from a hot summer to regular work and school schedules, this may help you avoid cooling off too fast. Please SUBSCRIBE for free e-alerts from the TI to receive email n
RePORT Thyroid survey invitation British Columbia (BC) healthcare workers, have you ordered a thyroid test or thyroid replacement recently? Literature and experts suggest that thyr
The association between hydrochlorothiazide (HCTZ) and skin cancer remains controversial. A team of investigators from the Canadian Network for Observational Drug Effect Studies (C
On September 5, 2019, British Columbia announced a new policy to switch from originator to biosimilar infliximab for patients with inflammatory bowel diseases (IBD). Subsequently,
The results of many clinical trials are not publicly reported, or reported only after a long delay. Why? Dr. Richard Morrow explored the views of trial participants, scientists, an
From the clinicians who brought you the highly acclaimed Best Science Medicine Course; Meds Conference; BS Medicine Podcast; Practical Evidence for Informed Practice (PEIP) Confere
The inaugural live Deprescribing Webinar took place on February 8, 2023. Scroll down to view the video recording. The next Deprescribing Webinar is scheduled for April 19, 2023. &#
When our founding Scientific Director Dr. Jim Wright started the Therapeutics Letter in 1994, our goals included relevance to practicing clinicians, accuracy, brevity, and critical